JP2013515270A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515270A5
JP2013515270A5 JP2012546198A JP2012546198A JP2013515270A5 JP 2013515270 A5 JP2013515270 A5 JP 2013515270A5 JP 2012546198 A JP2012546198 A JP 2012546198A JP 2012546198 A JP2012546198 A JP 2012546198A JP 2013515270 A5 JP2013515270 A5 JP 2013515270A5
Authority
JP
Japan
Prior art keywords
sample
acid
cancer
cancerous
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012546198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515270A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061811 external-priority patent/WO2011087845A2/en
Publication of JP2013515270A publication Critical patent/JP2013515270A/ja
Publication of JP2013515270A5 publication Critical patent/JP2013515270A5/ja
Pending legal-status Critical Current

Links

JP2012546198A 2009-12-22 2010-12-22 前立腺癌の代謝学的プロファイリング Pending JP2013515270A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28920609P 2009-12-22 2009-12-22
US61/289,206 2009-12-22
PCT/US2010/061811 WO2011087845A2 (en) 2009-12-22 2010-12-22 Metabolomic profiling of prostate cancer

Publications (2)

Publication Number Publication Date
JP2013515270A JP2013515270A (ja) 2013-05-02
JP2013515270A5 true JP2013515270A5 (enExample) 2014-01-23

Family

ID=44151645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546198A Pending JP2013515270A (ja) 2009-12-22 2010-12-22 前立腺癌の代謝学的プロファイリング

Country Status (5)

Country Link
US (2) US20110151497A1 (enExample)
EP (1) EP2517022A4 (enExample)
JP (1) JP2013515270A (enExample)
CN (1) CN102893157A (enExample)
WO (1) WO2011087845A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104169721A (zh) * 2012-02-23 2014-11-26 学校法人庆应义塾 并用抗癌剂的感受性判定标记
KR101462206B1 (ko) 2013-06-26 2014-11-20 한국과학기술연구원 트립토판 대사 변화를 이용한 위암 진단용 기초 정보 제공 방법
JP6222629B2 (ja) * 2013-08-29 2017-11-01 花王株式会社 排尿障害のバイオマーカー
KR101955430B1 (ko) * 2013-10-11 2019-03-11 주식회사 씨스퀘어 사르코신 대사산물 중 과산화물을 이용한 전립선암 진단 시험지, 그 제조 방법 및 이를 이용한 전립선암 진단에 필요한 정보를 제공하는 방법
CA2960696C (en) * 2014-09-10 2022-12-06 Idcgs Clinica De Diagnosticos Medicos Ltda Biomarkers for assessing breast cancer
WO2017210147A1 (en) * 2016-05-29 2017-12-07 Wei Jia Liver disease-related biomarkers and methods of use thereof
JP6692422B2 (ja) * 2016-06-10 2020-05-13 株式会社日立製作所 尿中代謝物による疾病診断法
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
CN106770873B (zh) * 2017-01-19 2019-02-19 中国人民解放军第四军医大学 一种膀胱癌诊断标志物及其应用和诊断试剂盒
CN108344830B (zh) * 2017-01-22 2020-10-16 中国科学院大连化学物理研究所 用于诊断前列腺癌的尿样组合标志物及检测试剂盒
KR102077058B1 (ko) * 2017-09-21 2020-02-13 연세대학교 산학협력단 대사체 프로파일링을 이용한 유방암의 예후 또는 위험도를 평가하는 방법 및 키트
CN108414661B (zh) * 2018-03-13 2020-04-21 中国医科大学 一种检测生物样品中氨含量的衍生化气相色谱-质谱方法
WO2019227235A1 (en) * 2018-06-01 2019-12-05 Lewis Ian Andrew Method for detecting urinary tract infections and sample analysis using liquid chromatography
IT201800007264A1 (it) * 2018-07-17 2020-01-17 Metodo per la diagnosi in vitro di carcinoma della prostata mediante biomarcatori urinari
KR102405789B1 (ko) * 2018-08-24 2022-06-07 고려대학교 세종산학협력단 키누레닌 경로 대사체를 포함하는 전립선암 진단용 바이오마커 조성물
EP3629021A1 (en) * 2018-09-26 2020-04-01 Euroimmun Medizinische Labordiagnostika AG Diagnosis of a neuroautoimmune disease
KR20210030883A (ko) * 2019-09-10 2021-03-18 고려대학교 세종산학협력단 인돌아민 2,3-이산소화 효소를 포함하는 전립선암 진단용 마커
JP7479504B2 (ja) * 2020-04-23 2024-05-08 ニュー ライフ メディシン テクノロジー カンパニー リミテッド 前立腺がんの診断に関連する方法
WO2022087593A1 (en) * 2020-10-20 2022-04-28 Baylor College Of Medicine Multiplex metabolic markers in plasma for early detection of african american prostrate cancer
JP7769179B2 (ja) * 2021-01-07 2025-11-13 住友化学株式会社 前立腺がんの罹患の可能性を検査する方法
CN114324674A (zh) * 2022-01-21 2022-04-12 苏州南医大创新中心 一种精液中与无精子症有关的分子标志物及其检测方法和应用
CN114487217B (zh) * 2022-02-14 2024-06-25 广州市番禺区中心医院 一种区分前列腺癌和良性前列腺增生的标志物及试剂盒
CN114544812B (zh) * 2022-02-18 2023-06-30 复旦大学附属中山医院 一种代谢组合式标志物在诊断哮喘中的应用
CN116465920B (zh) * 2023-04-03 2023-11-10 汕头大学医学院 用于诊断食管癌的代谢标志物
CN116106535B (zh) * 2023-04-11 2023-08-11 南京品生医学检验实验室有限公司 生物标志物组合在制备乳腺癌预测产品中的应用
US20250076301A1 (en) * 2023-09-05 2025-03-06 National Taiwan University Biomarker for prostate cancer
DE102023125870A1 (de) * 2023-09-25 2025-03-27 Numares Ag Verwendung eines Markersets für die Diagnostik des Prostatakarzinoms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020139A (en) * 1995-04-25 2000-02-01 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US6866837B2 (en) * 1998-06-05 2005-03-15 Mallinckrodt Inc. Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
EP2330219A3 (en) * 2000-04-14 2011-11-23 Metabolon, Inc. Method for drug discovery, disease treatment and diagnosis using metabolomics
US20050181375A1 (en) * 2003-01-10 2005-08-18 Natasha Aziz Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
CA2542661A1 (en) * 2003-10-16 2005-05-06 The Administrators Of The Tulane Educational Fund Methods and compositions for treating cancer
US20070055456A1 (en) * 2005-08-31 2007-03-08 Daniel Raftery NMR method for differentiating complex mixtures
WO2007066216A2 (en) * 2005-12-09 2007-06-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Fatty acids profile correlated to the propensity or risk of breast cancer
BRPI0709176A2 (pt) * 2006-03-24 2011-06-28 Phenomenome Discoveries Inc. biomarcadores úteis para diagnosticar o cáncer de próstata e seus métodos
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
WO2008036691A2 (en) * 2006-09-19 2008-03-27 Metabolon, Inc. Biomarkers for prostate cancer and methods using the same
CA2695674A1 (en) * 2007-08-16 2009-02-26 Metabolon, Inc. Metabolomic profiling of prostate cancer

Similar Documents

Publication Publication Date Title
JP2013515270A5 (enExample)
Li et al. Ultrasensitive and reversible nanoplatform of urinary exosomes for prostate cancer diagnosis
Mittal et al. Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies
Wang et al. Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes
Yin et al. A multifunctional platform for the capture, release, and enumeration of circulating tumor cells based on aptamer binding, nicking endonuclease-assisted amplification, and inductively coupled plasma mass spectrometry detection
EP3206034A3 (en) Use of fatty acids in methods for detecting cancer
BR112012032537B8 (pt) Métodos para diagnosticar se um indivíduo tem ou não câncer de pulmão de não pequenas células, ou para fornecer informações sobre câncer de pulmão de não pequenas células em um indivíduo
JP2009538607A5 (enExample)
JP2014144959A5 (enExample)
EP3988668A3 (en) Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor
CA2815892C (en) Analytical methods and arrays for use in the same
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
CN106066324B (zh) 一种电致化学发光生物传感器标记物的制备方法
MX2014004860A (es) Biomarcadores de cancer de pulmon y usos de los mismos.
JP2013522652A5 (enExample)
Li et al. Choline phosphate-grafted nanozymes as universal extracellular vesicle probes for bladder cancer detection
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
JP2009540314A5 (enExample)
JP2015518152A (ja) 前立腺がんの検出用バイオマーカーの定量
WO2012103337A3 (en) Assays and methods to sequence microbes directly from immune complexes
CN103424402A (zh) 一种体液巯基检测试剂盒
JP2010526995A5 (enExample)
CN203312251U (zh) 一种用于在扫描电镜下观察超薄圆片的样品托装置
JP2013513812A5 (enExample)